We are upgrading the repository! The content freeze has been extended to December 11, 2024, when we expect the new repository to become available. New submissions or changes to existing items will not be allowed until after the new website goes live. All content already published will remain publicly available for searching and downloading. Updates will be posted in the Website Upgrade 2024 FAQ in the sidebar Help menu. Reach out to escholarship@umassmed.edu with any questions.

Show simple item record

dc.contributor.authorWarwick, David
dc.contributor.authorFriedman, Richard J.
dc.contributor.authorAgnelli, Giancarlo
dc.contributor.authorGil-Garay, Enrique
dc.contributor.authorJohnson, Kirk
dc.contributor.authorFitzgerald, Gordon
dc.contributor.authorTuribio, Flavio
dc.date2022-08-11T08:08:08.000
dc.date.accessioned2022-08-23T15:43:38Z
dc.date.available2022-08-23T15:43:38Z
dc.date.issued2007-06-07
dc.date.submitted2011-09-21
dc.identifier.citationJ Bone Joint Surg Br. 2007 Jun;89(6):799-807. <a href="http://dx.doi.org/10.1302/0301-620X.89B6.18844">Link to article on publisher's site</a>
dc.identifier.issn0301-620X (Print)
dc.identifier.doi10.1302/0301-620X.89B6.18844
dc.identifier.pmid17613508
dc.identifier.urihttp://hdl.handle.net/20.500.14038/27141
dc.description.abstractPatients who have undergone total hip or knee replacement (THR and TKR, respectively) are at high risk of venous thromboembolism. We aimed to determine the time courses of both the incidence of venous thromboembolism and effective prophylaxis. Patients with elective primary THR and TKR were enrolled in the multi-national Global Orthopaedic Registry. Data on the incidence of venous thromboembolism and prophylaxis were collected from 6639 THR and 8326 TKR patients. The cumulative incidence of venous thromboembolism within three months of surgery was 1.7% in the THR and 2.3% in the TKR patients. The mean times to venous thromboembolism were 21.5 days (sd 22.5) for THR, and 9.7 days (sd 14.1) for TKR. It occurred after the median time to discharge in 75% of the THR and 57% of the TKA patients who developed venous thromboembolism. Of those who received recommended forms of prophylaxis, approximately one-quarter (26% of THR and 27% of TKR patients) were not receiving it seven days after surgery, the minimum duration recommended at the time of the study. The risk of venous thromboembolism extends beyond the usual period of hospitalisation, while the duration of prophylaxis is often shorter than this. Practices should be re-assessed to ensure that patients receive appropriate durations of prophylaxis.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=17613508&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1302/0301-620X.89B6.18844
dc.subjectAged
dc.subjectAnticoagulants
dc.subjectArthroplasty, Replacement, Hip
dc.subjectArthroplasty, Replacement, Knee
dc.subjectDrug Administration Schedule
dc.subjectFemale
dc.subjectHumans
dc.subjectMale
dc.subjectMiddle Aged
dc.subject*Registries
dc.subjectThromboembolism
dc.subjectTime Factors
dc.subjectVenous Thrombosis
dc.subjectHealth Services Research
dc.titleInsufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry
dc.typeJournal Article
dc.source.journaltitleThe Journal of bone and joint surgery. British volume
dc.source.volume89
dc.source.issue6
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/cor_glory/7
dc.identifier.contextkey2249949
html.description.abstract<p>Patients who have undergone total hip or knee replacement (THR and TKR, respectively) are at high risk of venous thromboembolism. We aimed to determine the time courses of both the incidence of venous thromboembolism and effective prophylaxis. Patients with elective primary THR and TKR were enrolled in the multi-national Global Orthopaedic Registry. Data on the incidence of venous thromboembolism and prophylaxis were collected from 6639 THR and 8326 TKR patients. The cumulative incidence of venous thromboembolism within three months of surgery was 1.7% in the THR and 2.3% in the TKR patients. The mean times to venous thromboembolism were 21.5 days (sd 22.5) for THR, and 9.7 days (sd 14.1) for TKR. It occurred after the median time to discharge in 75% of the THR and 57% of the TKA patients who developed venous thromboembolism. Of those who received recommended forms of prophylaxis, approximately one-quarter (26% of THR and 27% of TKR patients) were not receiving it seven days after surgery, the minimum duration recommended at the time of the study. The risk of venous thromboembolism extends beyond the usual period of hospitalisation, while the duration of prophylaxis is often shorter than this. Practices should be re-assessed to ensure that patients receive appropriate durations of prophylaxis.</p>
dc.identifier.submissionpathcor_glory/7
dc.contributor.departmentCenter for Outcomes Research
dc.source.pages799-807


This item appears in the following Collection(s)

Show simple item record